Prognostic role of multiple abnormal genes in non-small-cell lung cancer
Lu-Da Yan, Liu Yang, Na Li, Meng Wang, Yan-Hua Zhang, Wen Zhou, Zhi-Qiong Yu, Xiao-Chun Peng, Jun Cai
Lu-Da Yan, Liu Yang, Na Li, Meng Wang, Yan-Hua Zhang, Wen Zhou, Zhi-Qiong Yu, Jun Cai, Department of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou 434023, Hubei Province, China
Xiao-Chun Peng, Department of Pathophysiology, School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou 434023, Hubei Province, China
Author contributions: Yan LD, Peng XC, and Cai J designed the research; Yan LD, Yang L, Na Li, Peng XC, and Cai J performed the research; Wang M, Zhang YH, Zhou W, and Yu ZQ contributed new reagents/analytic tools; Yan LD, Peng XC, and Cai J analyzed the data; Yan LD and Cai J wrote the paper.
Supported by the Natural Science Foundation of Hubei Province, No. 2017CFB786; the Hubei Province Health and Family Planning Scientific Research Project, No. WJ2016Y10; the Jingzhou Science and Technology Bureau Project, No. 2017-93; and the College Students Innovative Entrepreneurial Training Program in Yangtze University, No. 2019376.
Institutional review board statement: The study was reviewed and approved by the Health Science Center of Yangtze University Institutional Review Board (Approval No. 2020-036).
Informed consent statement: The requirement to obtain informed consent was waived by Yangtze University Ethics Board.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Jun Cai, MD, PhD, Chief Doctor, Department of Oncology, The First Affiliated Hospital of Yangtze University, No. 1 Nanhuan Road, Jingzhou 434023, Hubei Province, China.
529369023@qq.com
Received: February 28, 2022
Peer-review started: February 28, 2022
First decision: May 11, 2022
Revised: May 19, 2022
Accepted: June 17, 2022
Article in press: June 17, 2022
Published online: August 6, 2022
Processing time: 143 Days and 23.2 Hours
